Viewing Study NCT00073346



Ignite Creation Date: 2024-05-05 @ 11:33 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00073346
Status: COMPLETED
Last Update Posted: 2020-01-21
First Post: 2003-11-19

Brief Title: Pilot Trial of Cognitive and Behavioral Treatment of Compulsive Hoarding Compared to Wait List Control
Sponsor: Boston University Charles River Campus
Organization: Boston University Charles River Campus

Study Overview

Official Title: Cognitive and Behavioral Treatment of Compulsive Hoarding
Status: COMPLETED
Status Verified Date: 2020-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study developed and tested a specialized cognitive and behavioral treatment for the symptoms of hoarding disorder including excessive acquiring difficulty discarding items and extensive clutter in the home
Detailed Description: Compulsive hoarding is characterized by excessive acquisition of possessions difficulty discarding possessions and excessive clutter This condition is resistant to standard pharmacological and psychotherapeutic interventions that have proven effective in treating other obsessive compulsive spectrum disorders This study aimed to determine the effectiveness of a specialized cognitive behavioral therapy CBT designed for treating hoarding symptoms

This study consists of three phases In Phase 1 pilot data from previous studies were examined to develop an intervention suitable for use in a waitlist trial In Phase 2 pilot study information were used to develop and test a treatment manual for compulsive hoarding During this phase treatment was applied flexibly to allow for variations in treatment duration and choice of techniques During Phase 3 participants were randomly assigned to 26 weekly sessions of CBT or to a 12-week wait-list control followed by active treatment for a fixed duration of 26 sessions Therapist adherence and competence were assessed through audiotaped therapy sessions

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
DATR A2-AIA US NIH GrantContract None httpsreporternihgovquickSearchR21MH068539
R21MH068539 NIH None None